Measurements of Sexual Steroids' Concentrations in Prostatic Tissue
NCT04256161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2021-08-27
Summary
In the investigators's previous work, measurements of intra-prostatic concentrations of sex steroids were determined on samples taken from the operating room using a punch.
In order to study the in-vivo intra-prostatic concentrations of sex steroid, it is necessary to validate a measurement technique performed on samples obtained by a biopsy needle used in standard care for prostate biopsy punctures allowing the diagnosis and follow-up of prostate cancer.
The aim of this project is to validate this measurement technique carried out on samples obtained by the biopsy needle and to define the optimal number of carrots obtained by biopsy offering dosage results comparable to the punch.
Conditions
Sponsors & Collaborators
-
Hopital Foch
lead OTHER
Principal Investigators
-
Yann NEUZILLET, PhD · Hopital Foch, Suresnes
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-26
- Primary Completion
- 2021-07-07
- Completion
- 2021-07-07
Countries
- France
Study Locations
More Related Trials
-
Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients
NCT01254513 ·Status: COMPLETED ·Phase: PHASE2
-
Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral Metastasis
NCT06536725 ·Status: RECRUITING
-
A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
NCT02066961 ·Status: COMPLETED
-
Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer
NCT00546039 ·Status: UNKNOWN ·Phase: PHASE2
-
Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy
NCT01915316 ·Status: COMPLETED
-
Glycosylation of Exosomes in Prostate and Urothelial Carcinoma
NCT04960956 ·Status: TERMINATED
-
The Safety and Dosimetry Study of 177Lu-LNC1003 Injection
NCT06237491 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy
NCT01450683 ·Status: TERMINATED ·Phase: PHASE2
-
Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs
NCT04662996 ·Status: COMPLETED ·Phase: NA
-
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
NCT06636123 ·Status: RECRUITING ·Phase: PHASE1
-
Assessment of Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure Without Androgen Deprivation Therapy
NCT06167824 ·Status: COMPLETED
-
PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy
NCT00966095 ·Status: UNKNOWN
-
PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer
NCT00898326 ·Status: COMPLETED
-
Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer
NCT01317641 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583
NCT00898833 ·Status: TERMINATED
-
Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
NCT00176631 ·Status: TERMINATED ·Phase: PHASE2
-
Nutrition and Prostate Cancer
NCT03532308 ·Status: TERMINATED ·Phase: PHASE3
-
Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer
NCT02370355 ·Status: TERMINATED
-
Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154
NCT00535834 ·Status: COMPLETED
-
Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001
NCT01429064 ·Status: COMPLETED ·Phase: PHASE2
-
In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies
NCT04873427 ·Status: TERMINATED
-
Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion
NCT06029998 ·Status: RECRUITING ·Phase: PHASE2
-
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
NCT05800665 ·Status: RECRUITING ·Phase: PHASE1
-
Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC
NCT03042468 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC
NCT02502994 ·Status: UNKNOWN ·Phase: PHASE1